These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6663314)

  • 21. [Effect of myoelectrostimulation on the status of peripheral hemodynamics in progressive muscular dystrophy].
    Avakian GN; Sadykova NF; Iakovlev IuV; Timonina OV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(11):33-7. PubMed ID: 6983797
    [No Abstract]   [Full Text] [Related]  

  • 22. Reduced adhesiveness between skin fibroblasts from patients with Duchenne muscular dystrophy.
    Jones GE; Witkowski JA
    J Neurol Sci; 1979 Nov; 43(3):465-70. PubMed ID: 521840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory muscle weakness in Charcot-Marie-Tooth disease. A field study.
    Nathanson BN; Yu DG; Chan CK
    Arch Intern Med; 1989 Jun; 149(6):1389-91. PubMed ID: 2730255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [External respiration in patients with progressive muscular dystrophy].
    Dunaevskaia GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(10):1471-6. PubMed ID: 5598401
    [No Abstract]   [Full Text] [Related]  

  • 25. Rehabilitation interventions for foot drop in neuromuscular disease.
    Sackley C; Disler PB; Turner-Stokes L; Wade DT; Brittle N; Hoppitt T
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003908. PubMed ID: 19588347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roussy-Levy hereditary areflexic dystasis presenting as Charcot-Marie-Tooth syndrome.
    Murdoch JL; Beighton PH
    Birth Defects Orig Artic Ser; 1971 Feb; 7(2):106-7. PubMed ID: 5173115
    [No Abstract]   [Full Text] [Related]  

  • 27. [Charcot-Marie neural amyotrophy (review)].
    Savchenko IuN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(11):1718-22. PubMed ID: 6098115
    [No Abstract]   [Full Text] [Related]  

  • 28. Progressive neuropathic (peroneal) muscular atrophy (Charcot-Marie-Tooth disease); histological findings in muscle biopsy specimens in fourteen cases, with notes on clinical diagnosis and familial occurrence.
    BRODAL A; BOYESEN S; FROVIG AG
    AMA Arch Neurol Psychiatry; 1953 Jul; 70(1):1-29. PubMed ID: 13057401
    [No Abstract]   [Full Text] [Related]  

  • 29. Skeletal changes in children with neuromuscular disorders.
    Hsu JD
    Prog Clin Biol Res; 1982; 101():553-7. PubMed ID: 7156158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotype of Charcot-Marie-Tooth disease Type 2.
    Bienfait HM; Baas F; Koelman JH; de Haan RJ; van Engelen BG; Gabreëls-Festen AA; Ongerboer de Visser BW; Meggouh F; Weterman MA; De Jonghe P; Timmerman V; de Visser M
    Neurology; 2007 May; 68(20):1658-67. PubMed ID: 17502546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extremity fractures in children with neuromuscular disease.
    Hsu JD
    Johns Hopkins Med J; 1979 Sep; 145(3):89-93. PubMed ID: 470294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ballerina steps, symptom disclosing hypertrophic Charcot-Marie disease with dominant transmission. Value of electrophysiological studies].
    Bady B; Chauplannaz G; Brunon AM
    Rev Neurol (Paris); 1982; 138(11):827-38. PubMed ID: 7167695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development of the extensor digitorium brevis muscle in progressive proximal muscular antrophies.
    Panayiotopoulos CP; Scarpalezos S
    Acta Neurol Scand; 1977 Dec; 56(6):579-86. PubMed ID: 605779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypersensitivity to N-methyl-N'-nitro-N-nitrosoguanidine in fibroblasts from patients with Huntington disease, familial dysautonomia, and other primary neuronal degenerations.
    Scudiero DA; Meyer SA; Clatterbuck BE; Tarone RE; Robbins JH
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6451-5. PubMed ID: 6458814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroneal musclar atrophy (of Charcot-Marie-Tooth) in two African brothers.
    Billinghurst JR
    Afr J Med Med Sci; 1976 Dec; 5(4):269-72. PubMed ID: 829740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
    Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
    J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between muscle atrophy on MRI and manual strength testing in hereditary neuropathies.
    del Porto LA; Nicholson GA; Ketheswaren P
    J Clin Neurosci; 2010 Jul; 17(7):874-8. PubMed ID: 20399669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial occurrence of neural muscle atrophy (Tooth-Marie-Charcot) combined with cerebral atrophy and parkinsonism.
    MOFFIE D
    Psychiatr Neurol Neurochir; 1961; 64():381-91. PubMed ID: 14475031
    [No Abstract]   [Full Text] [Related]  

  • 39. Possible neurogenic factor in muscular dystrophy: its similarity to denervation atrophy.
    Dastur DK; Razzak ZA
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):399-410. PubMed ID: 4714102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic linkage evidence for heterogeneity in Charcot-Marie-Tooth neuropathy (HMSN type I).
    Bird TD; Ott J; Giblett ER; Chance PF; Sumi SM; Kraft GH
    Ann Neurol; 1983 Dec; 14(6):679-84. PubMed ID: 6651251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.